These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15742634)

  • 1. Development of new concepts in vaccines and their effects on the control of infectious diseases (classical swine fever in particular).
    Vannier P
    Dev Biol (Basel); 2004; 119():235-41. PubMed ID: 15742634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker vaccine strategies and candidate CSFV marker vaccines.
    Dong XN; Chen YH
    Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
    Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
    Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinology of classical swine fever: from lab to field.
    van Oirschot JT
    Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.
    Rau H; Revets H; Balmelli C; McCullough KC; Summerfield A
    Vet Res; 2006; 37(1):155-68. PubMed ID: 16336932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the epidemiological and economic effects of control strategies against classical swine fever in Denmark.
    Boklund A; Toft N; Alban L; Uttenthal A
    Prev Vet Med; 2009 Aug; 90(3-4):180-93. PubMed ID: 19439381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors critical for successful vaccination against classical swine fever in endemic areas.
    Suradhat S; Damrongwatanapokin S; Thanawongnuwech R
    Vet Microbiol; 2007 Jan; 119(1):1-9. PubMed ID: 17097243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous vaccination against Aujeszky's disease and European hog cholera].
    Bengelsdorff HJ; Becker W; Steinhoff H; Barth R
    Berl Munch Tierarztl Wochenschr; 1985 Apr; 98(4):109-12. PubMed ID: 2986592
    [No Abstract]   [Full Text] [Related]  

  • 10. Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
    Vannie P; Capua I; Le Potier MF; Mackay DK; Muylkens B; Parida S; Paton DJ; Thiry E
    Rev Sci Tech; 2007 Aug; 26(2):351-72. PubMed ID: 17892157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker.
    Dong XN; Chen Y; Wu Y; Chen YH
    Vaccine; 2005 May; 23(28):3630-3. PubMed ID: 15882522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.
    van Aarle P
    Dev Biol (Basel); 2003; 114():193-200. PubMed ID: 14677689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.
    Koenig P; Hoffmann B; Depner KR; Reimann I; Teifke JP; Beer M
    Vet Microbiol; 2007 Mar; 120(3-4):343-51. PubMed ID: 17147979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples.
    Dewulf J; Koenen F; Ribbens S; Haegeman A; Laevens H; De Kruif A
    J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):367-71. PubMed ID: 16283914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication versus vaccination strategies to control infectious diseases--some lessons to be learned from terrestrial animals.
    Moennig V
    Dev Biol (Basel); 2005; 121():13-9. PubMed ID: 15962466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
    Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
    Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in new-type vaccines against classical swine fever].
    Wang C; Sun Y; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2013 Jul; 29(7):880-90. PubMed ID: 24195355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus.
    Dong XN; Chen YH
    Vaccine; 2006 May; 24(19):4029-34. PubMed ID: 16504346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?
    van Rijn PA
    Vet Microbiol; 2007 Nov; 125(1-2):150-6. PubMed ID: 17561359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.